Ke‐Ming Wang

机构：Tianjin Medical University Cancer Institute and Hospital, Second Affiliated Hospital of Nanjing Medical University · ORCID：0000-0002-7181-754X

发表论文 291 篇 · 总被引 4304 次 · h-index 35

代表论文

• A Novel lncRNA, LINC00460, Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer (2018 · Molecular Therapy — Nucleic Acids · 被引 105)
• Engineered exosomes for co‐delivery of PGM5‐AS1 and oxaliplatin to reverse drug resistance in colon cancer (2021 · Journal of Cellular Physiology · 被引 90)
• A comprehensive research on internal short circuits caused by copper particle contaminants on cathode in lithium-ion batteries (2022 · eTransportation · 被引 80)
• m6A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/ FOXM1 positive feedback loop (2024 · Cancer Letters · 被引 46)
• Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial (2017 · 癌症：英文版 · 被引 44)
• Association Between Abundance of Haemophilus in the Gut Microbiota and Negative Symptoms of Schizophrenia (2021 · Frontiers in Psychiatry · 被引 40)